Reply to: “Understanding the Contribution of Anti-EGFR Reinduction to Overall Survival in the TRIPLETE Study” and “TRIPLETE But Incomplete? Accounting for Postprogression Therapy When Interpreting Overall Survival”
Journal of Clinical Oncology · 10.08.2026 · 44 (23) · 2255-2257
DOI: 10.1200/jco-26-00870 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Oncology, erschienen am 10.08.2026. Verfasst von Veronica Conca und 2 weiteren Autor:innen. Beteiligte Einrichtung: Veronica Conca, MD, PhD, Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy, Department of Translational Research and …. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Veronica Conca, MD, PhD, Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy, Department of Translational Research and New Technology in Medicine and Surgery, University of Pisa, Pisa, Ital…
ORCID-Profile: Veronica Conca, Daniele Rossini, Chiara Cremolini
Zitieren
APA
Conca, V., Rossini, D., & Cremolini, C. (2026). Reply to: “Understanding the Contribution of Anti-EGFR Reinduction to Overall Survival in the TRIPLETE Study” and “TRIPLETE But Incomplete? Accounting for Postprogression Therapy When Interpreting Overall Survival”. Journal of Clinical Oncology, 44(23), 2255-2257. https://doi.org/10.1200/jco-26-00870
Vancouver
Conca V, Rossini D, Cremolini C. Reply to: “Understanding the Contribution of Anti-EGFR Reinduction to Overall Survival in the TRIPLETE Study” and “TRIPLETE But Incomplete? Accounting for Postprogression Therapy When Interpreting Overall Survival”. Journal of Clinical Oncology. 2026;44(23):2255-2257. doi:10.1200/jco-26-00870
BibTeX
@article{Conca2026,
author = {Conca, Veronica and Rossini, Daniele and Cremolini, Chiara},
title = {Reply to: “Understanding the Contribution of Anti-EGFR Reinduction to Overall Survival in the TRIPLETE Study” and “TRIPLETE But Incomplete? Accounting for Postprogression Therapy When Interpreting Overall Survival”},
journal = {Journal of Clinical Oncology},
year = {2026},
volume = {44},
number = {23},
pages = {2255--2257},
doi = {10.1200/jco-26-00870}
}
EUVIMED